We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SITM:NASDAQSiTime Corporation Analysis

Data as of 2026-05-01 - not real-time

$562.15

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

SiTime’s stock is trading well above its 20‑day (474), 50‑day (407) and 200‑day (325) moving averages, confirming a strong bullish technical backdrop, while the RSI of 70.4 signals an overbought condition. The MACD line sits above its signal line, producing a bullish histogram, and volume is on an upward trend, all of which support short‑term upward momentum.
However, the forward P/E of 84.3 dwarfs the industry average of 37.9, and a discounted cash‑flow fair‑value of $47.8 is starkly lower than the current price of $562, indicating that the market is pricing in a substantial premium. The company’s revenue surged 66% year‑over‑year with a solid 53.6% gross margin, yet operating and net margins remain negative, and EBITDA is in the red. A robust cash pile of $808 M versus minimal debt (Debt/Equity 0.31) provides liquidity, but high beta (2.56) and 30‑day volatility of 71% amplify price risk. The recent $1.5 B acquisition of Renesas’ timing business is a pivotal catalyst that could unlock new markets, but integration risk remains. Analyst consensus leans heavily bullish (strong‑buy) despite a median price target of $450, well below today’s level, underscoring the overvaluation concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Overbought RSI and price well above fair‑value DCF
  • Bullish technical momentum but elevated volatility
  • Upcoming Q1 2026 earnings could trigger price correction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Renesas acquisition provides strategic growth and market expansion
  • Strong revenue growth and high gross margins
  • Ample cash reserves to fund integration and R&D

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Positioning in AI, data‑center and IoT timing markets
  • Potential for margin improvement as integration matures
  • Low debt and sustainable cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth66.30%
Profit Margin-13.13%
P/E Ratio84.3
ROE-4.62%
ROA-3.57%
Debt/Equity0.31
P/B Ratio12.8
Op. Cash Flow$87.2M
Free Cash Flow$12.6M
Industry P/E37.9

Technical Analysis

TrendBullish
RSI70.4
Support$330.13
Resistance$591.13
MA 20$474.07
MA 50$407.33
MA 200$325.33
MACDBullish
VolumeIncreasing
Fear & Greed Index90.88

Valuation

Fair Value$47.82
Target Price$495.56
Upside/Downside-11.85%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.56
Volatility71.53%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.